2022
DOI: 10.1021/acs.jmedchem.1c02207
|View full text |Cite
|
Sign up to set email alerts
|

Induction of Genes Implicated in Stress Response and Autophagy by a Novel Quinolin-8-yl-nicotinamide QN523 in Pancreatic Cancer

Abstract: Using a cytotoxicity-based phenotypic screen of a highly diverse library of 20,000 small-molecule compounds, we identified a quinolin-8-yl-nicotinamide, QN519, as a promising lead. QN519 represents a novel scaffold with drug-like properties, showing potent in vitro cytotoxicity in a panel of 12 cancer cell lines. Subsequently, lead optimization campaign generated compounds with IC50 values < 1 μM. An optimized compound, QN523, shows significant in vivo efficacy in a pancreatic cancer xenograft model. QN523 tre… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 68 publications
(137 reference statements)
0
2
0
Order By: Relevance
“…We hypothesize that the basic 5-(5-(diethylamino)­pentan-2-yl)­amine tail moiety in CQ is responsible for σ1R binding. Recently, we identified the quinolyl pyrazinamide derivative QN523 as a promising lead compound, exhibiting significant cytotoxicity in pancreatic cancer cell lines . Accordingly, we thought to append the basic tail moiety of CQ to QN523 to explore this functional group for the identification of cytotoxic σR ligands exemplified by the hybrid structure 1 (Figure ).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…We hypothesize that the basic 5-(5-(diethylamino)­pentan-2-yl)­amine tail moiety in CQ is responsible for σ1R binding. Recently, we identified the quinolyl pyrazinamide derivative QN523 as a promising lead compound, exhibiting significant cytotoxicity in pancreatic cancer cell lines . Accordingly, we thought to append the basic tail moiety of CQ to QN523 to explore this functional group for the identification of cytotoxic σR ligands exemplified by the hybrid structure 1 (Figure ).…”
Section: Introductionmentioning
confidence: 99%
“…Recently, we identified the quinolyl pyrazinamide derivative QN523 as a promising lead compound, exhibiting significant cytotoxicity in pancreatic cancer cell lines. 47 Accordingly, we thought to append the basic tail moiety of CQ to QN523 to explore this functional group for the identification of cytotoxic σR ligands exemplified by the hybrid structure 1 (Figure 2). Grafting the CQ tail moiety allows for salt formation and potentially improves the solubility of the whole molecule.…”
Section: ■ Introductionmentioning
confidence: 99%